| Real-world experience with ceftazidime-avibactam for multidrug-resistant gram-negative bacterial infections SCJ Jorgensen, TD Trinh, EJ Zasowski, AM Lagnf, S Bhatia, SM Melvin, ... Open forum infectious diseases 6 (12), ofz522, 2019 | 133 | 2019 |
| Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: A Multicenter Study JC Gallagher, MJ Satlin, A Elabor, N Saraiya, EK McCreary, E Molnar, ... Open forum infectious diseases 5 (11), ofy280, 2018 | 122 | 2018 |
| Time is of the essence: the impact of delayed antibiotic therapy on patient outcomes in hospital-onset enterococcal bloodstream infections EJ Zasowski, KC Claeys, AM Lagnf, SL Davis, MJ Rybak Clinical Infectious Diseases 62 (10), 1242-1250, 2016 | 119 | 2016 |
| Association between vancomycin day 1 exposure profile and outcomes among patients with methicillin-resistant Staphylococcus aureus infective endocarditis AM Casapao, TP Lodise, SL Davis, KC Claeys, R Kullar, DP Levine, ... Antimicrobial agents and chemotherapy 59 (6), 2978-2985, 2015 | 102 | 2015 |
| Making the change to area under the curve–based vancomycin dosing EL Heil, KC Claeys, RP Mynatt, TL Hopkins, K Brade, I Watt, MJ Rybak, ... American Journal of Health-System Pharmacy 75 (24), 1986-1995, 2018 | 101 | 2018 |
| Multicenter observational study of ceftaroline fosamil for methicillin-resistant Staphylococcus aureus bloodstream infections EJ Zasowski, TD Trinh, KC Claeys, AM Casapao, N Sabagha, AM Lagnf, ... Antimicrobial agents and chemotherapy 61 (2), 10.1128/aac. 02015-16, 2017 | 82 | 2017 |
| Daptomycin improves outcomes regardless of vancomycin MIC in a propensity-matched analysis of methicillin-resistant Staphylococcus aureus bloodstream infections KC Claeys, EJ Zasowski, AM Casapao, AM Lagnf, JL Nagel, CT Nguyen, ... Antimicrobial agents and chemotherapy 60 (10), 5841-5848, 2016 | 82 | 2016 |
| Imipenem‐cilastatin‐relebactam: A novel β‐lactam–β‐lactamase inhibitor combination for the treatment of multidrug‐resistant gram‐negative infections JR Smith, JM Rybak, KC Claeys Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40 (4 …, 2020 | 70 | 2020 |
| Advances and challenges in the diagnosis and treatment of urinary tract infections: the need for diagnostic stewardship KC Claeys, N Blanco, DJ Morgan, S Leekha, KV Sullivan Current infectious disease reports 21, 1-9, 2019 | 60 | 2019 |
| Optimal urine culture diagnostic stewardship practice—results from an expert modified-Delphi procedure KC Claeys, BW Trautner, S Leekha, KC Coffey, CJ Crnich, DJ Diekema, ... Clinical Infectious Diseases 75 (3), 382-389, 2022 | 57 | 2022 |
| An antibiotic stewardship program blueprint for optimizing Verigene BC-GN within an institution: a tale of two cities JM Pogue, EL Heil, P Lephart, JK Johnson, RP Mynatt, H Salimnia, ... Antimicrobial Agents and Chemotherapy 62 (5), 10.1128/aac. 02538-17, 2018 | 55 | 2018 |
| Change in hospital antibiotic use and acquisition of multidrug-resistant gram-negative organisms after the onset of coronavirus disease 2019 JT Bork, S Leekha, K Claeys, H Seung, M Tripoli, A Amoroso, EL Heil Infection Control & Hospital Epidemiology 42 (9), 1115-1117, 2021 | 52 | 2021 |
| The battle is on: new beta-lactams for the treatment of multidrug-resistant Gram-negative organisms M Noval, M Banoub, KC Claeys, E Heil Current Infectious Disease Reports 22, 1-9, 2020 | 46 | 2020 |
| Impact of the combination of daptomycin and trimethoprim-sulfamethoxazole on clinical outcomes in methicillin-resistant Staphylococcus aureus infections KC Claeys, JR Smith, AM Casapao, RP Mynatt, L Avery, A Shroff, ... Antimicrobial Agents and Chemotherapy 59 (4), 1969-1976, 2015 | 45 | 2015 |
| Real-world, multicenter experience with meropenem-vaborbactam for gram-negative bacterial infections including carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa S Alosaimy, AM Lagnf, T Morrisette, MR Scipione, JJ Zhao, ... Open forum infectious diseases 8 (8), ofab371, 2021 | 43 | 2021 |
| Multidrug-resistant Pseudomonas aeruginosa lower respiratory tract infections in the intensive care unit: prevalence and risk factors TD Trinh, EJ Zasowski, KC Claeys, AM Lagnf, S Kidambi, SL Davis, ... Diagnostic microbiology and infectious disease 89 (1), 61-66, 2017 | 43 | 2017 |
| A Review of Novel Combinations of Colistin and Lipopeptide or Glycopeptide Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii KC Claeys, AD Fiorvento, MJ Rybak Infectious diseases and therapy 3, 69-81, 2014 | 43 | 2014 |
| Fluoroquinolone restriction as an effective antimicrobial stewardship intervention KC Claeys, TL Hopkins, AD Vega, EL Heil Current Infectious Disease Reports 20, 1-7, 2018 | 41 | 2018 |
| Early experience with eravacycline for complicated infections S Alosaimy, KC Molina, KC Claeys, J Andrade, J Truong, MA King, ... Open Forum Infectious Diseases 7 (5), ofaa071, 2020 | 40 | 2020 |
| Pharmacokinetic/pharmacodynamic considerations of beta-lactam antibiotics in adult critically ill patients AM Masich, MS Heavner, JP Gonzales, KC Claeys Current infectious disease reports 20, 1-8, 2018 | 40 | 2018 |
